Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure

Int J Cardiol. 2015 Dec 15:201:1-3. doi: 10.1016/j.ijcard.2015.07.072. Epub 2015 Jul 31.

Authors

Affiliations

¹ Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
² Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan. Electronic address: dohik@clin.medic.mie-u.ac.jp.
³ Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Japan.

PMID: 26278671
DOI: 10.1016/j.ijcard.2015.07.072

No abstract available

Keywords: Diabetes mellitus; Diuretics; Heart failure; Sodium–glucose cotransporter 2 inhibitor.

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / epidemiology
Diuretics / pharmacology
Diuretics / therapeutic use*
Female
Glucosides / pharmacology
Glucosides / therapeutic use*
Heart Failure / diagnosis
Heart Failure / drug therapy*
Heart Failure / epidemiology
Humans
Male
Middle Aged
Prospective Studies
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors*
Thiophenes / pharmacology
Thiophenes / therapeutic use*

Substances

Diuretics
Glucosides
SLC5A2 protein, human
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors
Thiophenes
ipragliflozin